Accessibility Menu
 
Nuvalent logo

Nuvalent

(NASDAQ) NUVL

Current Price$96.64
Market Cap$7.60B
Since IPO (2021)+416%
5 YearN/A
1 Year+31%
1 Month-8%

Nuvalent Financials at a Glance

Market Cap

$7.60B

Revenue (TTM)

$0.00

Net Income (TTM)

$425.38M

EPS (TTM)

$-5.85

P/E Ratio

-16.52

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$96.64

Volume

19,582

Open

$98.29

Previous Close

$96.64

Daily Range

$95.87 - $98.85

52-Week Range

$55.53 - $113.02

NUVL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nuvalent

Industry

Biotechnology

Employees

228

CEO

James R. Porter, PhD

Headquarters

Cambridge, MA 02142, US

NUVL Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-37%

Return on Capital

-31%

Return on Assets

-30%

Earnings Yield

-6.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.60B

Shares Outstanding

78.62M

Volume

19.58K

Short Interest

0.00%

Avg. Volume

534.50K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$414.31M

EBITDA

$10.48M

Operating Cash Flow

$275.21M

Capital Expenditure

$0.00

Free Cash Flow

$275.21M

Cash & ST Invst.

$1.37B

Total Debt

$0.00

Nuvalent Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.60B

N/A

Market Cap/Employee

$46.91M

N/A

Employees

162

N/A

Net Income

$118.70M

-58.8%

EBITDA

$16.33M

+81.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.37B

+22.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-30.11%

N/A

Return on Invested Capital

-31.35%

N/A

Free Cash Flow

$73.33M

-18.3%

Operating Cash Flow

$73.33M

-18.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCVXVaxcyte, Inc.
$53.16-2.83%
CYTKCytokinetics, Incorporated
$62.50-1.54%
MTSRMetsera, Inc.
$70.50-0.35%
AXSMAxsome Therapeutics, Inc.
$156.35-4.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About NUVL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.